|
公司基本資料信息
|
I-0103 | IGF-I (1-3), GPE | C12H19N3O6 | 301.30 | 32302-76-4 | H-Gly-Pro-Glu-OH |
I-0104 | IGF-I (24-41) | C88H133N27O28 | 2017.19 | 135861-49-3 | H-Tyr-Phe-Asn-Lys-Pro-Thr-Gly-Tyr-Gly-Ser-Ser-Ser-Arg-Arg-Ala-Pro-Gln-Thr-OH |
I-0105 | IGF-I (30-41), IGF-I C-Peptide | C51H83N19O19 | 1266.34 | 82177-09-1 | H-Gly-Tyr-Gly-Ser-Ser-Ser-Arg-Arg-Ala-Pro-Gln-Thr-OH |
I-0106 | IGF-II (33-40), IGF-II C-Peptide | C38H74N20O12 | 1003.13 | 103244-41-3 | H-Ser-Arg-Val-Ser-Arg-Arg-Ser-Arg-OH |
I-0107 | Lys-Lys-IRS-1 (891-902) (dephosphorylated) (human), Lys-Lys-Insulin Receptor Substrate-1 (891-902) (dephosphorylated) (human), Lys-Lys-IRS-1 (886-897) (dephosphorylated) (mouse), Lys-Lys-IRS-1 (890-901) (dephosphorylated) (rat), IGF1RK Peptide Substrate | C73H114N18O22 | 1595.82 | 172615-51-9 | H-Lys-Lys-Lys-Ser-Pro-Gly-Glu-Tyr-Val-Asn-Ile-Glu-Phe-Gly-OH |
I-0201 | Insulin B (22-25) | C26H35N7O5 | 525.61 | 34367-73-2 | H-Arg-Gly-Phe-Phe-OH |
I-0301 | AF12198 | C96H123N19O22 | 1895.15 | 185413-30-3 | Ac-Phe-Glu-Trp-Thr-Pro-Gly-Trp-Tyr-Gln-L-azetidine-2-carbonyl-Tyr-Ala-Leu-Pro-Leu-NH2 |
I-0302 | IL-1α (223-250) (human) Interleukin-1α (223-250) (human) |
C158H219N37O44 | 3340.70 | ? | H-Phe-Phe-Tyr-Glu-Thr-His-Gly-Thr-Lys-Asn-Tyr-Phe-Thr-Ser-Val-Ala-His-Pro-Asn-Leu-Phe-Ile-Ala-Thr-Lys-Gln-Asp-Tyr-OH |
I-0303 | IL-1β (163-171) (human), Interleukin-1β (163-171) (human) | C39H64N12O19 | 1005.01 | 106021-96-9 | H-Val-Gln-Gly-Glu-Glu-Ser-Asn-Asp-Lys-OH |
I-0304 | IL-1β (178-207) (human) Interleukin-1β (178-207) (human) |
C157H256N38O49S | 3492.05 | ? | H-Leu-Lys-Glu-Lys-Asn-Leu-Tyr-Leu-Ser-Cys-Val-Leu-Lys-Asp-Asp-Lys-Pro-Thr-Leu-Gln-Leu-Glu-Ser-Val-Asp-Pro-Lys-Asn-Tyr-Pro-OH |